From August 6 to 8, we participated in CCiC & Synbiopunk 2025 in Beijing, engaging with scholars, industry leaders, and over 100 iGEM teams. We presented our project through a professional booth, poster sessions, and a formal roadshow. We also joined roundtable discussions on topics such as “The Next Leap in DNA Synthesis” and “Generative AI in Life Sciences,” and held a one-on-one meeting with Mr. Mark Dupal, Vice President of Twist Bioscience Asia-Pacific, who offered advice on scaling production and navigating regulatory pathways. These interactions helped us identify key bottlenecks in technology transfer and refine our quality control and documentation processes. Our project, which closely links CRISPR innovation with clinical needs, also served as an inspiring case for other teams aiming for real-world application.